Two schedules of application for mesna and their influence on the thiol-metabolism.
Kempgens
B
B
University of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Kisro
J
J
Gruber
Y
Y
Bahrs
H
H
Wagner
Th
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D015080:Mesna / Q000008:administration & dosage* / Q000494:pharmacology*; D009369:Neoplasms / Q000188:drug therapy; D020011:Protective Agents / Q000008:administration & dosage* / Q000494:pharmacology*; D013438:Sulfhydryl Compounds / Q000378:metabolism*
D020011:Protective Agents; D013438:Sulfhydryl Compounds; D015251:Epirubicin; D005047:Etoposide; D015080:Mesna; D007069:Ifosfamide